The present invention provides for thiazolopyridine-based tricyclic compounds having the formula (I), wherein R.sup.1, R.sup.2, R.sup.5 and R.sup.6 are as described herein. The present invention further provides pharmaceutical compositions comprising such compounds, as well as the use of such compounds for treating inflammatory and immune diseases.

 
Web www.patentalert.com

< Process for preparing novel crystalline forms of (2S)-1-[[(7R)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyr- imidine-6-yl]carbonyl]-2-(4-fluorophenyl)pyrrolidine, novel stable forms produced therein and formulations

< Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists

> Chemical compounds

> Non-steroidal farnesoid x receptor modulators and methods for the use thereof
~ 00270